Amarin Corp Plc (AMRN)

[Whalatane]

Sharinky. The patent issue re Omega Via EPA 500 is interesting ... and maybe you have some insight you can share .

Amarin is claiming composition of matter patents for capsules containing 70% EPA up to 96 EPA . Their key patent that JL has referred to in the past was 96% EPA devoid of DHA
Epadel used in the JELIS trial had 2% DHA ....
Omega Via EPA is about 85 % EPA ( some DHA )
PlusEPA is also very high EPA with some DHA and was on the market ... in the public domain .. well before Amarin filed its key patent

So how does Amarins patent claims for compositions as low as 70% EPA hold ?

Before some of you start on this “ gas lighting “ thing ... R-It results are based on 96% pure EPA devoid of DHA ... and no one has ever to my knowledge produced such a product ... ie. No prior art , never in the public domain

Those compositions with less EPA and containing some DHA will certainly be less effective with no clinical Outcome results ... except Epadel ... proving significant benefit

Kiwi